GridAI Technologies (GRDX) Change in Accured Expenses (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Change in Accured Expenses came in at -$251403.0 in Q4 2025, down 61.11% YoY from -$646469.0 in Q4 2024, and down 4810.21% on a QoQ basis from -$5120.0 in Q3 2025.
GridAI Technologies (GRDX) Change in Accured Expenses (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Change in Accured Expenses data on file, last reported at -$251403.0 in Q4 2025.
- Quarterly Change in Accured Expenses fell 61.11% year-over-year to -$251403.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$93127.0 (up 41.9% YoY) and the FY2025 annual result came in at -$93127.0, up 41.9% from the prior year.
- Change in Accured Expenses slipped to -$251403.0 in Q4 2025, from -$5120.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.6 million in Q4 2023 to a low of -$930144.0 in Q1 2022.
- A 5-year average of $80940.8 and a median of -$9259.0 in 2021 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses sank 792.48% — and 2024, when it jumped 162146.67%.
- Tracing GRDX's Change in Accured Expenses over 5 years: stood at -$58035.0 in 2021, then jumped by 182.55% to $47908.0 in 2022, then surged by 3279.87% to $1.6 million in 2023, then plunged by 109.64% to -$156043.0 in 2024, then sank by 61.11% to -$251403.0 in 2025.
- The last three Change in Accured Expenses figures came in at -$251403.0 (Q4 2025), -$5120.0 (Q3 2025), and -$252670.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 212.44 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 61.62 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 68.82 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | -31,603.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -251,403.00 |
| Dec 31, 2025 | -251,403.00 |
| Sep 30, 2025 | -5,120.00 |
| Sep 30, 2025 | -5,120.00 |
| Jun 30, 2025 | -252,670.00 |
| Jun 30, 2025 | -252,670.00 |
| Mar 31, 2025 | 416,066.00 |
| Mar 31, 2025 | 416,066.00 |
| Dec 31, 2024 | -156,043.00 |
| Dec 31, 2024 | -156,043.00 |
| Sep 30, 2024 | 776,398.00 |
| Sep 30, 2024 | 776,398.00 |
| Jun 30, 2024 | -804,944.00 |
| Jun 30, 2024 | -804,944.00 |
| Mar 31, 2024 | 24,307.00 |
| Mar 31, 2024 | 24,307.00 |
| Dec 31, 2023 | 1.62 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | -161,018.00 |
| Sep 30, 2023 | -161,018.00 |